search
Back to results

Fighting Fatty Liver in India (FFL)

Primary Purpose

NAFLD

Status
Unknown status
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Diet change (red rice)
Yoga
Sponsored by
University of Nottingham
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for NAFLD

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion criteria

  • aged 18 years or over
  • Male
  • Able to give informed consent
  • NAFLD diagnosis showing Fatty/echo-bright liver on ultrasound within past 3 months
  • Able to attend yoga sessions
  • Able to undergo MRI
  • Consumer of at least 300g (uncooked weight) white rice per day (on average)
  • No allergy to red rice or lentils
  • Medically suitable for repeated blood sampling

Exclusion criteria

  • Known or suspected cirrhosis on clinical/histological/radiological grounds
  • Current or recent history of significant alcohol consumption (>14units per week)
  • Other documented causes of chronic liver disease including:

    • Hepatitis B or C infection
    • Drug-induced liver disease
    • Alcohol-related liver disease
    • Autoimmune hepatitis
    • Wilson's disease, Haemachromatosis
    • Primary biliary cirrhosis, Primary Sclerosing Cholangitis
  • Currently taking medication that can induce steatosis (corticosteroids, Amiodarone, Tamoxifen, Methotrexate)
  • Evidence of any other unstable or untreated clinically significant immunological, endocrine, haematological, gastrointestinal, neurological, neoplastic or psychiatric disease
  • *Female

    • A number of gender specific confounders (menstrual cycle, age etc) mean that mechanistic studies in small sample sizes are limited to men. The local cohort being used comprises males only.

Sites / Locations

  • Population Health and Research InstituteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Diet change (red rice) with yoga

Yoga

Arm Description

Following randomisation, participants are given a schedule of group and personal meetings and details of each session. Food for the diet (red rice and lentils) will be provided for those randomised to the diet arm. The study will last 16 weeks following start of the diet/yoga programme. There will be further visits to measure outcomes at week 8 and week 16. All participants in both arms will complete the same programme of Yoga sessions, organized and delivered by experienced practitioners under direction of Dr Leena Mohan at the Holistic Health and Research Institute.

Following randomisation, participants are given a schedule of group and personal meetings and details of each session. The study will last 16 weeks following start of the diet/yoga programme. There will be further visits to measure outcomes at week 8 and week 16. All participants in both arms will complete the same programme of Yoga sessions, organized and delivered by experienced practitioners under direction of Dr Leena Mohan at the Holistic Health and Research Institute.

Outcomes

Primary Outcome Measures

Change in liver fat
Measured by MRI, comparing liver fat pre- and post-intervention.

Secondary Outcome Measures

Change in body composition
Measured by body fat % via bioimpedance
Change in body composition
Measured by BMI (kg/m2)
Change in insulin sensitivity
Measured by oral glucose tolerance test (OGTT)

Full Information

First Posted
February 11, 2019
Last Updated
February 13, 2019
Sponsor
University of Nottingham
Collaborators
Population Health and Research Institute, Trivandrum, Kerala, india, Holistic Health and Research Institute, Trivandrum, Kerala, India
search

1. Study Identification

Unique Protocol Identification Number
NCT03844165
Brief Title
Fighting Fatty Liver in India
Acronym
FFL
Official Title
Fighting the Fatty Liver Pandemic: Developing Effective Protocols & Local Expertise to Deliver & Evaluate Diet/Lifestyle Interventions for Better Liver & Metabolic Health in India
Study Type
Interventional

2. Study Status

Record Verification Date
February 2019
Overall Recruitment Status
Unknown status
Study Start Date
January 1, 2019 (Actual)
Primary Completion Date
July 31, 2019 (Anticipated)
Study Completion Date
December 31, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Nottingham
Collaborators
Population Health and Research Institute, Trivandrum, Kerala, india, Holistic Health and Research Institute, Trivandrum, Kerala, India

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to build capacity in India by: Developing tailored protocol methodologies for research including technical capability in imaging (MRI/S protocols & customised software), dietary intervention delivery, dietary evaluation, and biochemical analyses, using available local resources in Kerala. Training and enhancing imaging skills of clinical radiographers in Kerala for research studies Training local professionals and researchers in skills necessary to design, deploy and evaluate diet/lifestyle interventions, including patient engagement, in Kerala. This study will deliver and evaluate a simple dietary intervention pilot study in the Kerala region in conjunction with local nutritionists, healthcare professionals and partner researchers at PHRI (Population Health and Research Institute, Trivandrum, Kerala, India).
Detailed Description
STUDY BACKGROUND INFORMATION AND RATIONALE Non-alcoholic fatty liver disease (NAFLD): With an estimated global prevalence of 25% among adults, NAFLD is now the commonest chronic liver disease; its progressive form, non-alcoholic steatohepatitis (NASH), has been estimated to affect 1.5%-6.5% of the population with associated increased risk of cirrhosis, hepatocellular carcinoma and liver-specific mortality. Considering the key association of fat accumulation within the liver, in particular diacyl glycerols, to the generation of whole body insulin resistance and development of type 2 diabetes, NAFLD has been considered a pre-diabetic state. NAFLD has been associated with excess risk of non-fatal and fatal cardiovascular events independently of established co-morbidities including type 2 diabetes, dyslipidemia and obesity. Individuals of South Asian ethnicity have significantly higher rates of NAFLD, abdominal obesity and cardiovascular disease than whites and ethnicity is a risk factor for NAFLD independent of diabetes, BMI, hypertension and hypercholesterolemia. NAFLD problem in India: Consistent with the global trend, the health and economic burdens of metabolic syndrome and NAFLD have risen in India. In 2011, India had 63 million individuals with type 2 diabetes and by 2030, that number is predicted to be a staggering 90 million. Insulin resistance (IR) has also been shown to be more prevalent in Indians compared with other ethnic groups and this has been correlated with NAFLD regardless of adiposity. Despite these links, there are a number of key differences between Indian NAFLD patients and those in the West: mean BMI is significantly lower in Indians and there is also a lower prevalence of hypertension, diabetes and metabolic syndrome in non-cirrhotic NAFLD patients. Dietary influences on NAFLD: Diet may be one of the key environmental factors that accounts for ethnic variation in susceptibility to NAFLD. However, there is currently a lack of research into specific dietary factors influencing susceptibility to NAFLD, in particular, with regards to macronutrients, and there are few evidence-based dietary interventions, beyond energy restriction to induce weight loss. Considering the effectiveness of a modest increase in protein content and a reduction in the glycaemic index (GI) in maintaining weight loss, we investigated the effects of a low GI diet on the liver and demonstrated that it did not increase liver fat content whereas an increase was seen with an isoenergetic high GI diet controlled for macronutrient content. Diet has been found to influence the gut microbiome variably across human societies. Fibre encompassing a range of characteristics, is one of the fundamental components linking diet, the gut microbiome and fatty acid metabolism. The benefits of dietary fibre include improved glucose homeostasis and insulin sensitivity. Dietary fibres are at least partly fermented in the caecum and large intestine by the colonic microbiota resulting in some cases an increased production of short chain fatty acids (SCFAs) which regulate the balance between fatty acid synthesis, fatty acid oxidation and lipolysis in the body. The net result is a reduction in free fatty acid concentrations in plasma and a decrease in body weight. Dietary fibre overall is associated with greater gut microbiome diversity and we have recently shown that it is also associated with lower long-term weight gain.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
NAFLD

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is two-arm dietary interventional study that will be conducted through the Population Health and Research Institute, Trivandrum, India. Participants will be randomised to one of two study arms: diet change with yoga or yoga. We will aim to recruit 42 participants to each arm.
Masking
Investigator
Masking Description
The participant and study team will not be blinded to this allocation, although the scientist and radiology team will be blinded when analysing samples/scans.
Allocation
Randomized
Enrollment
84 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Diet change (red rice) with yoga
Arm Type
Experimental
Arm Description
Following randomisation, participants are given a schedule of group and personal meetings and details of each session. Food for the diet (red rice and lentils) will be provided for those randomised to the diet arm. The study will last 16 weeks following start of the diet/yoga programme. There will be further visits to measure outcomes at week 8 and week 16. All participants in both arms will complete the same programme of Yoga sessions, organized and delivered by experienced practitioners under direction of Dr Leena Mohan at the Holistic Health and Research Institute.
Arm Title
Yoga
Arm Type
Active Comparator
Arm Description
Following randomisation, participants are given a schedule of group and personal meetings and details of each session. The study will last 16 weeks following start of the diet/yoga programme. There will be further visits to measure outcomes at week 8 and week 16. All participants in both arms will complete the same programme of Yoga sessions, organized and delivered by experienced practitioners under direction of Dr Leena Mohan at the Holistic Health and Research Institute.
Intervention Type
Behavioral
Intervention Name(s)
Diet change (red rice)
Intervention Description
This interventions specifically aims to reduce liver inflammation, by replacing white rice in the diet with equal amounts of red rice and lentils. This will also enable for the research team to tests specific scientific hypotheses regarding the effects of diet on insulin resistance, liver pathology and the gut microbiome in NAFLD.
Intervention Type
Behavioral
Intervention Name(s)
Yoga
Intervention Description
All 84 study participants take part in the yoga intervention. This is an intensive programme organized and delivered by experienced practitioners under direction of Dr Leena Mohan at the Holistic Health and Research Institute. This will evaluate whether physical activity alone improves metabolic health of the liver.
Primary Outcome Measure Information:
Title
Change in liver fat
Description
Measured by MRI, comparing liver fat pre- and post-intervention.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Change in body composition
Description
Measured by body fat % via bioimpedance
Time Frame
1 year
Title
Change in body composition
Description
Measured by BMI (kg/m2)
Time Frame
1 year
Title
Change in insulin sensitivity
Description
Measured by oral glucose tolerance test (OGTT)
Time Frame
1 year

10. Eligibility

Sex
Male
Gender Based
Yes
Gender Eligibility Description
A number of gender specific confounders (menstrual cycle, age etc) mean that mechanistic studies in small sample sizes are limited to men. The local cohort being used comprises males only.
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria aged 18 years or over Male Able to give informed consent NAFLD diagnosis showing Fatty/echo-bright liver on ultrasound within past 3 months Able to attend yoga sessions Able to undergo MRI Consumer of at least 300g (uncooked weight) white rice per day (on average) No allergy to red rice or lentils Medically suitable for repeated blood sampling Exclusion criteria Known or suspected cirrhosis on clinical/histological/radiological grounds Current or recent history of significant alcohol consumption (>14units per week) Other documented causes of chronic liver disease including: Hepatitis B or C infection Drug-induced liver disease Alcohol-related liver disease Autoimmune hepatitis Wilson's disease, Haemachromatosis Primary biliary cirrhosis, Primary Sclerosing Cholangitis Currently taking medication that can induce steatosis (corticosteroids, Amiodarone, Tamoxifen, Methotrexate) Evidence of any other unstable or untreated clinically significant immunological, endocrine, haematological, gastrointestinal, neurological, neoplastic or psychiatric disease *Female A number of gender specific confounders (menstrual cycle, age etc) mean that mechanistic studies in small sample sizes are limited to men. The local cohort being used comprises males only.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Guruprasad P Aithal
Phone
01158231149
Email
guru.aithal@nottingham.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Jane Grove
Phone
01158231149
Email
jane.grove@nottingham.ac.uk
Facility Information:
Facility Name
Population Health and Research Institute
City
Trivandrum
State/Province
Kerala
Country
India
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thrivikrama Shenoy
Email
dr.ktshenoy@gmail.com
First Name & Middle Initial & Last Name & Degree
Leena Mohan
Email
leenakb@yahoo.com

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Fighting Fatty Liver in India

We'll reach out to this number within 24 hrs